Decaudin D - Search Results

1

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.

Coussy F, El-Botty R, Château-Joubert S, Dahmani A, Montaudon E, Leboucher S, Morisset L, Painsec P, Sourd L, Huguet L, Nemati F, Servely JL, Larcher T, Vacher S, Briaux A, Reyes C, La Rosa P, Lucotte G, Popova T, Foidart P, Sounni NE, Noel A, Decaudin D, Fuhrmann L, Salomon A, Reyal F, Mueller C, Ter Brugge P, Jonkers J, Poupon MF, Stern MH, Bièche I, Pommier Y, Marangoni E. Coussy F, et al. Among authors: decaudin d. Sci Transl Med. 2020 Feb 19;12(531):eaax2625. doi: 10.1126/scitranslmed.aax2625. Sci Transl Med. 2020. PMID: 32075943 Free PMC article.

2

Distinct experimental efficacy of anti-Fas/APO-1/CD95 receptor antibody in human tumors.

Decaudin D, Beurdeley-Thomas A, Nemati F, Miccoli L, Pouillart P, Bourgeois Y, Gonçalves RB, Rouillard D, Poupon MF. Decaudin D, et al. Exp Cell Res. 2001 Aug 15;268(2):162-8. doi: 10.1006/excr.2001.5287. Exp Cell Res. 2001. PMID: 11478842

3

Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo.

Decaudin D, Castedo M, Nemati F, Beurdeley-Thomas A, De Pinieux G, Caron A, Pouillart P, Wijdenes J, Rouillard D, Kroemer G, Poupon MF. Decaudin D, et al. Cancer Res. 2002 Mar 1;62(5):1388-93. Cancer Res. 2002. PMID: 11888910

4

In vivo efficacy of STI571 in xenografted human small cell lung cancer alone or combined with chemotherapy.

Decaudin D, de Cremoux P, Sastre X, Judde JG, Nemati F, Tran-Perennou C, Fréneaux P, Livartowski A, Pouillart P, Poupon MF. Decaudin D, et al. Int J Cancer. 2005 Feb 20;113(5):849-56. doi: 10.1002/ijc.20652. Int J Cancer. 2005. PMID: 15499612 Free article. Review.

5

Fine-needle aspiration cytology combined with flow cytometry immunophenotyping is a rapid and accurate approach for the evaluation of suspicious superficial lymphoid lesions.

Mathiot C, Decaudin D, Klijanienko J, Couturier J, Salomon A, Dumont J, Vielh P. Mathiot C, et al. Among authors: decaudin d. Diagn Cytopathol. 2006 Jul;34(7):472-8. doi: 10.1002/dc.20487. Diagn Cytopathol. 2006. PMID: 16783780

6

High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.

Decaudin D, Marszak FB, Couturier J, Mathiot C, Martin A, Némati F, Lantz O, Santo Jd, Arnaud P, Bordier V, Vincent-Salomon A, Poupon MF. Decaudin D, et al. Anticancer Drugs. 2006 Jul;17(6):685-95. doi: 10.1097/01.cad.0000215061.78189.4e. Anticancer Drugs. 2006. PMID: 16917214

7

Imatinib mesylate reduces rituximab-induced tumor-growth inhibition in vivo on Epstein-Barr virus-associated human B-cell lymphoma.

Némati F, Mathiot C, Grandjean I, Lantz O, Bordier V, Dewulf S, Ekue R, Di Santo JP, Poupon MF, Decaudin D. Némati F, et al. Among authors: decaudin d. Anticancer Drugs. 2007 Oct;18(9):1029-37. doi: 10.1097/CAD.0b013e3281e444cb. Anticancer Drugs. 2007. PMID: 17704653

8

Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide.

Rezaï K, Lokiec F, Grandjean I, Weill S, de Cremoux P, Bordier V, Ekue R, Garcia M, Poupon MF, Decaudin D. Rezaï K, et al. Among authors: decaudin d. BMC Pharmacol. 2007 Oct 27;7:13. doi: 10.1186/1471-2210-7-13. BMC Pharmacol. 2007. PMID: 17963518 Free PMC article.

9

CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts.

Marangoni E, Lecomte N, Durand L, de Pinieux G, Decaudin D, Chomienne C, Smadja-Joffe F, Poupon MF. Marangoni E, et al. Among authors: decaudin d. Br J Cancer. 2009 Mar 24;100(6):918-22. doi: 10.1038/sj.bjc.6604953. Epub 2009 Feb 24. Br J Cancer. 2009. PMID: 19240712 Free PMC article.

10

Preclinical assessment of cisplatin-based therapy versus docetaxel-based therapy on a panel of human non-small-cell lung cancer xenografts.

Némati F, Bras-Gonçalves R, Fontaine JJ, de Pinieux G, De Cremoux P, Chapelier A, Daniel C, Laurent-Puig P, Livartowski A, Judde JG, Bordier V, Poupon MF, Decaudin D. Némati F, et al. Among authors: decaudin d. Anticancer Drugs. 2009 Nov;20(10):932-40. doi: 10.1097/CAD.0b013e32833009cc. Anticancer Drugs. 2009. PMID: 19741504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page